NTLA – Intellia Therapeutics, Inc.
Name :
Sector :
Industry:
Mark. Cap: $0.0000
EPSttm :
Float Short %
25.01
Margin Of Safety %
Put/Call OI Ratio
0.31
EPS Next Q Diff
-0.02
EPS Last/This Y
EPS This/Next Y
0.02
Price
12.18
Target Price
49.45
Analyst Recom
1.56
Performance Q
-14.11
Relative Volume
1.56
Beta
1.97
Ticker: NTLA
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-01-23 | NTLA | 11.3 | 0.25 | 0.13 | 37587 |
| 2025-01-24 | NTLA | 10.98 | 0.26 | 0.08 | 38132 |
| 2025-01-27 | NTLA | 10.57 | 0.26 | 0.04 | 38178 |
| 2025-01-28 | NTLA | 10 | 0.27 | 0.17 | 37429 |
| 2025-01-29 | NTLA | 10.12 | 0.27 | 0.33 | 37664 |
| 2025-01-30 | NTLA | 10.52 | 0.27 | 1.02 | 38262 |
| 2025-01-31 | NTLA | 10.31 | 0.28 | 0.75 | 39283 |
| 2025-02-03 | NTLA | 9.54 | 0.30 | 0.85 | 40188 |
| 2025-02-04 | NTLA | 9.61 | 0.32 | 0.09 | 41763 |
| 2025-02-05 | NTLA | 10.52 | 0.31 | 0.15 | 42348 |
| 2025-02-06 | NTLA | 10.12 | 0.32 | 0.38 | 42769 |
| 2025-02-07 | NTLA | 9.79 | 0.32 | 0.54 | 43027 |
| 2025-02-10 | NTLA | 9.58 | 0.32 | 0.20 | 43278 |
| 2025-02-11 | NTLA | 9.22 | 0.32 | 0.12 | 43609 |
| 2025-02-12 | NTLA | 9.53 | 0.31 | 0.30 | 44019 |
| 2025-02-13 | NTLA | 9.65 | 0.31 | 0.62 | 44307 |
| 2025-02-14 | NTLA | 10.7 | 0.31 | 0.23 | 44406 |
| 2025-02-18 | NTLA | 11.5 | 0.32 | 0.15 | 44472 |
| 2025-02-19 | NTLA | 12.28 | 0.32 | 0.11 | 45437 |
| 2025-02-20 | NTLA | 12.26 | 0.31 | 0.09 | 48534 |
| 2025-02-21 | NTLA | 12.14 | 0.31 | 0.07 | 48373 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-01-23 | NTLA | 11.29 | 9.7 | -119.0 | -5.15 |
| 2025-01-24 | NTLA | 10.98 | 9.7 | -53.1 | -5.15 |
| 2025-01-27 | NTLA | 10.57 | 9.7 | -40.0 | -5.15 |
| 2025-01-28 | NTLA | 10.00 | 9.7 | -19.7 | -5.15 |
| 2025-01-29 | NTLA | 10.10 | 9.7 | -99.7 | -5.15 |
| 2025-01-30 | NTLA | 10.51 | 9.8 | -139.4 | -5.15 |
| 2025-01-31 | NTLA | 10.30 | 9.8 | -61.4 | -5.15 |
| 2025-02-03 | NTLA | 9.54 | 9.8 | 12.5 | -5.15 |
| 2025-02-04 | NTLA | 9.62 | 9.8 | -100.9 | -5.15 |
| 2025-02-05 | NTLA | 10.52 | 9.8 | -216.0 | -5.15 |
| 2025-02-06 | NTLA | 10.13 | 9.8 | -40.3 | -5.15 |
| 2025-02-07 | NTLA | 9.81 | 9.8 | -44.1 | -5.15 |
| 2025-02-10 | NTLA | 9.58 | 9.8 | -57.5 | -5.15 |
| 2025-02-11 | NTLA | 9.22 | 9.8 | -32.4 | -5.15 |
| 2025-02-12 | NTLA | 9.53 | 9.8 | -141.4 | -5.15 |
| 2025-02-13 | NTLA | 9.64 | 9.8 | -107.3 | -5.15 |
| 2025-02-14 | NTLA | 10.70 | 9.8 | -245.3 | -5.15 |
| 2025-02-18 | NTLA | 11.53 | 9.8 | -185.9 | -5.15 |
| 2025-02-19 | NTLA | 12.28 | 9.8 | -164.7 | -5.15 |
| 2025-02-20 | NTLA | 12.26 | 9.8 | -85.3 | -5.15 |
| 2025-02-21 | NTLA | 12.18 | 9.8 | -80.7 | -5.15 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-01-23 | NTLA | -3.30 | 7.68 | 21.71 |
| 2025-01-24 | NTLA | -3.30 | 7.68 | 21.71 |
| 2025-01-27 | NTLA | -3.30 | 7.48 | 21.71 |
| 2025-01-28 | NTLA | -3.20 | 7.48 | 24.13 |
| 2025-01-29 | NTLA | -3.20 | 7.48 | 24.13 |
| 2025-01-30 | NTLA | -3.20 | 7.48 | 24.13 |
| 2025-01-31 | NTLA | -3.21 | 7.48 | 24.13 |
| 2025-02-03 | NTLA | -3.21 | 3.69 | 24.13 |
| 2025-02-04 | NTLA | -3.21 | 3.69 | 24.13 |
| 2025-02-05 | NTLA | -3.21 | 3.69 | 24.13 |
| 2025-02-06 | NTLA | -3.21 | 3.69 | 24.13 |
| 2025-02-07 | NTLA | -3.21 | 3.69 | 24.13 |
| 2025-02-10 | NTLA | -3.21 | 2.85 | 24.13 |
| 2025-02-11 | NTLA | -1.12 | 2.85 | 25.17 |
| 2025-02-12 | NTLA | -1.12 | 2.85 | 25.16 |
| 2025-02-13 | NTLA | -1.19 | 2.85 | 25.05 |
| 2025-02-14 | NTLA | -1.19 | 2.85 | 25.05 |
| 2025-02-18 | NTLA | -1.19 | 0.65 | 25.07 |
| 2025-02-19 | NTLA | -1.22 | 0.65 | 25.02 |
| 2025-02-20 | NTLA | -1.22 | 0.65 | 25.02 |
| 2025-02-21 | NTLA | -1.23 | 0.65 | 25.01 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.34
Avg. EPS Est. Current Quarter
-1.33
Avg. EPS Est. Next Quarter
-1.36
Insider Transactions
-1.23
Institutional Transactions
0.65
Beta
1.97
Average Sales Estimate Current Quarter
8
Average Sales Estimate Next Quarter
10
Fair Value
Quality Score
18
Growth Score
35
Sentiment Score
50
Actual DrawDown %
94
Max Drawdown 5-Year %
-94.8
Target Price
49.45
P/E
Forward P/E
PEG
P/S
28.77
P/B
1.29
P/Free Cash Flow
EPS
-5.45
Average EPS Est. Cur. Y
-5.15
EPS Next Y. (Est.)
-5.14
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-1212.19
Relative Volume
1.56
Return on Equity vs Sector %
-73.5
Return on Equity vs Industry %
-57.9
EPS 1 7Days Diff
EPS 1 30Days Diff
0.22
EBIT Estimation
-80.7
stock quote shares NTLA – Intellia Therapeutics, Inc. Stock Price stock today
news today NTLA – Intellia Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch NTLA – Intellia Therapeutics, Inc. yahoo finance google finance
stock history NTLA – Intellia Therapeutics, Inc. invest stock market
stock prices NTLA premarket after hours
ticker NTLA fair value insiders trading